Curcumin protects neuronal-like cells against acrolein by restoring Akt and redox signaling pathways

Molecular Nutrition and Food Research

Volumn 57, Issue 9, 2013, Pages 1660-1670

  Doggui, Sihem ^a   Belkacemi, Abdenour ^a   Paka, Ghislain Djiokeng ^a   Perrotte, Morgane ^a   Pi, Rongbiao ^b   Ramassamy, Charles ^a,c  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

Akt; Alzheimer's disease; Glutathione; Nrf2; Sirtuins

Indexed keywords

ACROLEIN; ANTIOXIDANT; CURCUMIN; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NANOPARTICLE; NEUROPROTECTIVE AGENT; NFE2L2 PROTEIN, HUMAN; PROTEIN KINASE B; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SIRT1 PROTEIN, HUMAN; SIRTUIN; SIRTUIN 1; TRANSCRIPTION FACTOR NRF2;

AKT; ALZHEIMER DISEASE; ARTICLE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; NERVE CELL; NEUROBLASTOMA; NRF2; OXIDATION REDUCTION REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AKT; ALZHEIMER'S DISEASE; GLUTATHIONE; NRF2; SIRTUINS;

ACROLEIN; ANTIOXIDANTS; CELL LINE, TUMOR; CURCUMIN; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; HUMANS; NANOPARTICLES; NEUROBLASTOMA; NEURONS; NEUROPROTECTIVE AGENTS; NF-E2-RELATED FACTOR 2; NF-KAPPA B; OXIDATION-REDUCTION; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SIRTUIN 1;

EID: 84883376966     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300130     Document Type: Article

References (56)

1. Christen, Y., Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 2000, 71, 621S-629S.
2. Sonnen, J. A., Breitner, J. C., Lovell, M. A., Markesbery, W. R. et al., Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. Free Radic. Biol. Med. 2008, 45, 219-230.
3. Lopez, N., Tormo, C., De Blas, I., Llinares, I. et al., Oxidative stress in Alzheimer's disease and mild cognitive impairment with high sensitivity and specificity. J. Alzheimers Dis. 2012, 33, 823-829.
4. Belkacemi, A., Ramassamy, C., Time sequence of oxidative stress in the brain from transgenic mice models of Alzheimer's disease related to the amyloid-ß cascade. Free Radic. Biol. Med. 2012, 52, 593-600.
5. Portet, F., Ousset, P. J., Visser, P. J., Frisoni, G. B. et al., Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J. Neurol. Neurosurg. Psychiatry 2006, 77, 714-718.
6. Guidi, I., Galimberti, D., Lonati, S., Novembrino, C. et al., Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 2006, 27, 262-269.
7. Reed, T., Perluigi, M., Sultana, R., Pierce, W. M. et al., Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol. Dis. 2008, 30, 107-120.
8. Calingasan, N. Y., Uchida, K., Gibson, G. E., Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J. Neurochem. 1999, 72, 751-756.
9. Lovell, M. A., Xie, C., Markesbery, W. R., Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 2001, 22, 187-194.
10. Williams, T. I., Lynn, B. C., Markesbery, W. R., Lovell, M. A., Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease. Neurobiol. Aging 2006, 27, 1094-1099.
11. Liu, X., Lovell, M. A., Lynn, B. C., Development of a method for quantification of acrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/MS/MS and its application to human brain tissue. Anal. Chem. 2005, 77, 5982-5989.
12. Liu, X., Lovell, M. A., Lynn, B. C., Detection and quantification of endogenous cyclic DNA adducts derived from trans-4-hydroxy-2-nonenal in human brain tissue by isotope dilution capillary liquid chromatography nanoelectrospray tandem mass spectrometry. Chem. Res. Toxicol. 2006, 19, 710-718.
13. Huang, Y. J., Jin, M. H., Pi, R. B., Zhang, J. J. et al., Acrolein induces Alzheimer's disease-like pathologies in vitro and in vivo. Toxicol. Lett. 2013, 217, 184-191.
14. Esterbauer, H., Schaur, R. J., Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11, 81-128.
15. Hinson, J. A., Roberts, D. W., Role of covalent and noncovalent interactions in cell toxicity: effects on proteins. Annu. Rev. Pharmacol. Toxicol. 1992, 32, 471-510.
16. Picklo, M. J., Montine, T. J., Acrolein inhibits respiration in isolated brain mitochondria. Biochim. Biophys. Acta 2001, 1535, 145-152.
17. Roy, J., Pallepati, P., Bettaieb, A., Tanel, A. et al., Acrolein induces a cellular stress response and triggers mitochondrial apoptosis in A549 cells. Chem. Biol. Interact. 2009, 181, 154-167.
18. Tanel, A., Averill-Bates, D. A., The aldehyde acrolein induces apoptosis via activation of the mitochondrial pathway. Biochim. Biophys. Acta 2005, 1743, 255-267.
19. Tanel, A., Averill-Bates, D. A., P38 and ERK mitogen-activated protein kinases mediate acrolein-induced apoptosis in Chinese hamster ovary cells. Cell Signal. 2007, 19, 968-977.
20. Tanel, A., Averill-Bates, D. A., Activation of the death receptor pathway of apoptosis by the aldehyde acrolein. Free Radic. Biol. Med. 2007, 42, 798-810.
21. Thanh Nam, D., Arseneault, M., Zarkovic, N., Waeg, G. et al., Molecular regulations induced by acrolein in neuroblastoma SK-N-SH cells: relevance to Alzheimer's disease. J. Alzheimers Dis. 2010, 21, 1197-1216.
22. Calingasan, N. Y., Chen, J., Kiaei, M., Beal, M. F., Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients. Neurobiol. Dis. 2005, 19, 340-347.
23. Zhu, Q., Liang, C. P., Cheng, K. W., Peng, X. et al., Trapping effects of green and black tea extracts on peroxidation-derived carbonyl substances of seal blubber oil. J. Agric. Food Chem. 2009, 57, 1065-1069.
24. Zhu, Q., Zheng, Z. P., Cheng, K. W., Wu, J. J. et al., Natural polyphenols as direct trapping agents of lipid peroxidation-derived acrolein and 4-hydroxy-trans-2-nonenal. Chem. Res. Toxicol. 2009, 22, 1721-1727.
25. Beretta, G., Furlanetto, S., Regazzoni, L., Zarrella, M. et al., Quenching of alpha, beta-unsaturated aldehydes by green tea polyphenols: HPLC-ESI-MS/MS studies. J. Pharm. Biomed. Anal. 2008, 48, 606-611.
26. Ringman, J. M., Frautschy, S. A., Teng, E., Begum, A. N. et al., Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res. Ther. 2012, 4, 43-50.
27. Belkacemi, A., Doggui, S., Dao, L., Ramassamy, C., Challenges associated with curcumin therapy in Alzheimer disease. Expert Rev. Mol. Med. 2011, 13, e34.
28. Doggui, S., Sahni, J. K., Arseneault, M., Dao, L. et al., Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line. J. Alzheimers Dis. 2012, 30, 377-392.
29. Castelo-Branco, G., Rawal, N., Arenas, E., GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. J. Cell Sci. 2004, 117, 5731-5737.
30. Singh, M., Nam, D. T., Arseneault, M., Ramassamy, C., Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein. J. Alzheimers Dis. 2010, 2193, 741-756.
31. Bradley, M. A., Markesbery, W. R., Lovell, M. A., Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer's disease (PCAD). Free Radic. Biol. Med. 2010, 48, 1570-1576.
32. Singh, M., Arseneault, M., Sanderson, T., Murthy, V. et al., Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms. J. Agric. Food Chem. 2008, 56, 4855-4873.
33. Kim, H., Park, B. S., Lee, K. G., Choi, C. Y. et al., Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J. Agric. Food Chem. 2005, 53, 8537-8541.
34. Zhang, C., Browne, A., Child, D., Tanzi, R. E., Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein. J. Biol. Chem. 2010, 285, 28472-28480.
35. Garcia-Alloza, M., Borrelli, L. A., Rozkalne, A., Hyman, B. T. et al., Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J. Neurochem. 2007, 102, 1095-1104.
36. Ma, Q. L., Zuo, X., Yang, F., Ubeda, O. J. et al., Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice. J. Biol. Chem. 2013, 288, 4056-4065.
37. Sreejayan, N., Rao, M. N., Nitric oxide scavenging by curcuminoids. J. Pharm. Pharmacol. 1997, 49, 105-107.
38. Saldanha, L. A., Elias, G., Rao, M. N., Oxygen radical scavenging activity of phenylbutenones and their correlation with antiinflammatory activity. Arzneimittelforschung 1990, 40, 89-91.
39. El-Demerdash, F. M., Yousef, M. I., Radwan, F. M., Ameliorating effect of curcumin on sodium arsenite-induced oxidative damage and lipid peroxidation in different rat organs. Food Chem. Toxicol. 2009, 47, 249-254.
40. Misonou, Y., Asahi, M., Yokoe, S., Miyoshi, E. et al., Acrolein produces nitric oxide through the elevation of intracellular calcium levels to induce apoptosis in human umbilical vein endothelial cells: implications for smoke angiopathy. Nitric Oxide 2006, 14, 180-187.
41. Adams, J. D., Jr., Klaidman, L. K., Acrolein-induced oxygen radical formation. Free Radic. Biol. Med. 1993, 15, 187-193.
42. Uchida, K., Kanematsu, M., Sakai, K., Matsuda, T. et al., Protein-bound acrolein: potential markers for oxidative stress. Proc. Natl. Acad. Sci. USA 1998, 95, 4882-4887.
43. Shamoto-Nagai, M., Maruyama, W., Hashizume, Y., Yoshida, M. et al., In parkinsonian substantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity. J. Neural. Transm. 2007, 114, 1559-1567.
44. Kakefuda, K., Fujita, Y., Oyagi, A., Hyakkoku, K. et al., Sirtuin 1 overexpression mice show a reference memory deficit, but not neuroprotection. Biochem. Biophys. Res. Commun. 2009, 387, 784-788.
45. Zhao, L., Lee, J. Y., Hwang, D. H., The phosphatidylinositol 3-kinase/Akt pathway negatively regulates Nod2-mediated NF-kappaB pathway. Biochem. Pharmacol. 2008, 75, 1515-1525.
46. Singh, S., Aggarwal, B. B., Activation of transcription factor NF-kappaB is suppressed by curcumin (diferuloylmethane) [corrected]. J. Biol. Chem. 1995, 270, 24995-25000.
47. Hayden, M. S., Ghosh, S., Signaling to NF-kappaB. Genes Dev. 2004, 18, 2195-2224.
48. Buhrmann, C., Mobasheri, A., Busch, F., Aldinger, C. et al., Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 2011, 286, 28556-28566.
49. Leu, T. H., Maa, M. C., The molecular mechanisms for the antitumorigenic effect of curcumin. Curr. Med. Chem. Anticancer Agents. 2002, 2, 357-370.
50. Milacic, V., Banerjee, S., Landis-Piwowar, K. R., Sarkar, F. H. et al., Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Res. 2008, 68, 7283-7292.
51. Manning, B. D., Cantley, L. C., AKT/PKB signaling: navigating downstream. Cell 2007, 129, 1261-1274.
52. Huang, Y., Jin, M., Pi, R., Zhang, J. et al., Protective effects of caffeic acid and caffeic acid phenethyl ester against acrolein-induced neurotoxicity in HT22 mouse hippocampal cells. Neurosci. Lett. 2013, 535, 146-151.
53. Lee, J. E., Kang, J. S., Ki, Y. W., Lee, S. H. et al., Akt/GSK3beta signaling is involved in fipronil-induced apoptotic cell death of human neuroblastoma SH-SY5Y cells. Toxicol. Lett. 2011, 202, 133-141.
54. Chen, G., Bower, K. A., Ma, C., Fang, S. et al., Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death. FASEB J. 2004, 18, 1162-1164.
55. Mittal, G., Carswell, H., Brett, R., Currie, S. et al., Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology. J. Control. Release 2011, 150, 220-228.
56. Allemann, E., Leroux, J. C., Gurny, R., Doelker, E., In vitro extended-release properties of drug-loaded poly(DL-lactic acid) nanoparticles produced by a salting-out procedure. Pharm. Res. 1993, 10, 1732-1737.